Hørsholm, Denmark

Klaus Peter Bøgesø



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2005-2008

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Klaus Peter Bøgesø: Innovator in Serotonin and Glycine Transport Inhibition

Introduction

Klaus Peter Bøgesø is a notable inventor hailing from Hørsholm, Denmark. With a focus on pharmaceutical innovations, he has made significant contributions to the field, resulting in the award of two patents to date. His research primarily revolves around the development of compounds with therapeutic potential in treating various diseases.

Latest Patents

Bøgesø's latest patents include:

1. **Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors** - This patent concerns aminoindane derivatives characterized by specific molecular structures, which exhibit the combined effect of serotonin reuptake inhibition and norepinephrine uptake inhibition. These compounds hold promise for developing new treatments for mood disorders.

2. **Compounds and their use as glycine transport inhibitors** - This invention provides novel compounds that inhibit glycine transporters, potentially aiding in the treatment of diseases responsive to their inhibition. The patent also outlines a pharmaceutical composition for utilizing these compounds effectively in medical settings.

Career Highlights

Klaus Peter Bøgesø is currently affiliated with H. Lundbeck A/S, a global pharmaceutical company renowned for its focus on brain health. His role at the company allows him to leverage his expertise in medicinal chemistry and contribute to groundbreaking drug development initiatives.

Collaborations

Throughout his career, Bøgesø has collaborated with esteemed colleagues, including Ejner Knud Moltzen and Paul Garrick Smith. These partnerships have been pivotal in advancing his research and enhancing the impact of his innovations in the pharmaceutical landscape.

Conclusion

Klaus Peter Bøgesø exemplifies the spirit of innovation in the pharmaceutical industry. Through his patents on serotonin and glycine transport inhibitors, he has opened new avenues for therapeutic interventions. As drug development continues to evolve, his contributions will undoubtedly play a crucial role in shaping future treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…